Comparing Nateglinide vs Repaglinide
Nateglinide | Repaglinide |
|
---|
Nateglinide | Repaglinide |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Type 2 Diabetes. Nateglinide may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Type 2 Diabetes. Repaglinide may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
|
|||||||||||||||
More about Nateglinide | More about Repaglinide | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Nateglinide has an average rating of 5.4 out of 10 from a total of 5 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 40% reported a negative effect. |
Repaglinide has an average rating of 7.8 out of 10 from a total of 12 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 8% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Nateglinide side effects |
View all Repaglinide side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Nateglinide prices |
View all Repaglinide prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Starlix | Prandin | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
1.5 hours |
1 hour |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 448 drugs are known to interact with Nateglinide:
|
A total of 545 drugs are known to interact with Repaglinide:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
December 22, 2000 |
December 22, 1997 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.